Trial Profile
A Multicentre, Open-label Extension Phase to Study the Long-term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Feb 2017
Price :
$35
*
At a glance
- Drugs Itopride (Primary)
- Indications Non-ulcer dyspepsia
- Focus Adverse reactions
- Sponsors Adare Pharmaceuticals
- 10 Feb 2017 New trial record